由买买提看人间百态

topics

全部话题 - 话题: prodrugs
1 (共1页)
b*****h
发帖数: 783
1
来自主题: _pennystock版 - 2011 biotech 系列(1)--XNPT
XNPT 是一家利用nutrient transport 开发prodrug的biotech公司,目前主要的
pipeline是XP19986(治疗GERD and
Spasticity). XP13512(治疗 restless legs syndrome).
XP13512 是 transported prodrug of gabapentin
由于gabapentin在preclinical有致癌可能,2010年FDA把它拒了。年底重新submit,
PDUFA在4/6/2011。
XP19986是transported prodrug of baclofen.
GERD (gastroesophageal reflux disease)的人群很大,美国估计有60MM, 所以,治
疗GERD的药物市场不小。目前主要
的治疗是离子通道抑制剂(PPI)抑制胃酸分泌.
XP19986的上一个phaseII结果negative,但是通过分析,发现部分对ppi有反应的人群
XP19986的效果是positive的,所
以,又在这部分人群上做了一个二期。结果在最近会随时出来(1Q 2011)... 阅读全帖
b*****h
发帖数: 783
2
来自主题: _pennystock版 - 2011 biotech 系列(1)--XNPT
XNPT 是一家利用nutrient transport 开发prodrug的biotech公司,目前主要的
pipeline是XP19986(治疗GERD and
Spasticity). XP13512(治疗 restless legs syndrome).
XP13512 是 transported prodrug of gabapentin
由于gabapentin在preclinical有致癌可能,2010年FDA把它拒了。年底重新submit,
PDUFA在4/6/2011。
XP19986是transported prodrug of baclofen.
GERD (gastroesophageal reflux disease)的人群很大,美国估计有60MM, 所以,治
疗GERD的药物市场不小。目前主要
的治疗是离子通道抑制剂(PPI)抑制胃酸分泌.
XP19986的上一个phaseII结果negative,但是通过分析,发现部分对ppi有反应的人群
XP19986的效果是positive的,所
以,又在这部分人群上做了一个二期。结果在最近会随时出来(1Q 2011)... 阅读全帖
g******o
发帖数: 33
3
中国的法官太二了,看看烙印怎么玩的。
Cipla launched a generic version of valganciclovir in 2008 while the anti-
viral was under patent in India
The Indian Patent Office has reversed an earlier decision granting patent
rights to an anti-viral drug valganciclovir marketed by Roche.
Valganciclovir is used for the treatment of active cytomegalovirus (CMV)
retinitis that occur in people living with HIV.
The Indian Patent Office at Chennai, in a decision released on April 30,
2010, has set aside the patent granted to ... 阅读全帖
L*******a
发帖数: 824
4
The position is available immediately at Department of Pharmaceutical
Sciences, College of Pharmacy, University of Nebraska Medical Center, under
the mentoring of Dr. Dong Wang. Our research interests are:
Macromolecular therapies for inflammatory diseases.
Dentrotropic therapies for oral and craniofacial diseases.
Targeted therapies for musculoskeletal diseases.
Click chemistry for drug delivery and nanomedicine.
Biocompatible polymers for biomedical applications.
Prodru... 阅读全帖
I****a
发帖数: 407
5
来自主题: Medicine版 - 替国内朋友发帖:胰腺癌晚期
XOLODA是fluorouracil的prodrug.
l***f
发帖数: 618
6
来自主题: Immigration版 - 审稿机会-polymer chemistry
今天收到一个审稿,RSC的polymer chemistry.
我最近太忙同时也不是我的研究方向,贡献给合适的人。请相关方向的人给我发信,把
你的简介和publication给我,我推荐你。并希望你能在那里用你的official 的email
先注册好帐号。
"Camptothecin prodrug block copolymer micelles with high drug loading and
target specificity"
m*****f
发帖数: 157
7
来自主题: Immigration版 - 求文献
请帮忙下载这篇文章:
Zhang Y, Sun J, Sun Y, Wang Y, He Z.Prodrug design targeting intestinal
PepT1 for improved oral absorption: design and performance.
Curr Drug Metab. 2013 Jul;14(6):675-87.
PMID: 23869811
谢谢啦~~:)
发送:[email protected]
(function(){try{var s,a,i,j,r,c,l,b=document.getElementsByTagName("script");l=b[b.length-1].previousSibling;a=l.getAttribute('data-cfemail');if(a){s='';r=parseInt(a.substr(0,2),16);for(j=2;a.length-j;j+=2){c=parseInt(a.substr(j,2),16)^r;s+=String.fromCharCode(c);}s=documen... 阅读全帖
i********n
发帖数: 171
8
来自主题: Immigration版 - 审稿
Please send your CV to [email protected]/* */ with selected MS#. 请务必认真审稿并及
时提交意见,谢谢
1. Iptakalim induces mitochondria-dependent apoptosis in hypoxic rat
pulmonary arterial smooth muscle cells
2. Fyn-related kinase expression predicts favorable prognosis in patients
with cervical cancer and suppresses malignant progression by regulating
migration and invasion
3. The Protective effect of Citrus limon essential oil on Hepatotoxicity
and nephrotoxicity induced by aspirin in rats
4. ... 阅读全帖
i********n
发帖数: 171
9
来自主题: Immigration版 - 多多审稿机会-生物医学
请发简历及你想审稿的文章编号, 尽量会照顾大家,一般给我邮件都有机会,尽量多
选几篇你相关的领域。
同时提醒一下审稿人,请重视审稿质量,希望大家都有下一次审稿机会。
Please email to: [email protected]/* */
1. Identification of novel VP35 inhibitors: virtual screening driven new
scaffolds
2. Long non-coding RNA SNHG5, which is downregulated by estradiol,
suppresses breast cancer cell proliferation
3. anti-inflammatory, analgesic and antipyretic activities of grapevine
leaf extract (Vitis vinifera) in mice and identification of its active
constituents by LC-MS/MS ... 阅读全帖
i********n
发帖数: 171
10
来自主题: Immigration版 - 生物医学审稿人
请发简历以及相应的审稿文章编号到[email protected]/* */
1. Possible Contributions of Thyroid Hormone Replacement to Specific
Behaviors of Cancer
2. ATTENUATING EFFECT OF GYMNEMA SYLVESTRE ON STREPTOZOTOCIN-NICOTINAMIDE
INDUCED DIABETIC NEPHROPATHY IN RATS
3. Estrogen and Thyroid Cancer is a stem affair. A preliminary study
4. Therapeutic outcomes of autologous CIK cells as a maintenance therapy
in the treatment of lung cancer patients: A retrospective study
5. Role of gastrointestinal motili... 阅读全帖
S***A
发帖数: 40
11
来自主题: SanDiego版 - 4th SABPA/ACS Chemistry Symposium
DATE: Monday, April 7, 2014
TIME:
4:45 PM Registration
5:15 PM Professor Barry M. Trost, Tamaki Professor of Humanities and
Sciences, Stanford University, “The Alkyne Strategy For the Synthesis of
Bioactive Targets”
6:00 PM Networking and light dinner
7:00 PM Dr. Nicholas A. Meanwell, Executive Director, Medicinal
Chemistry, Bristol-Myers Squibb, “The Discovery of HCV NS5A Replication
Complex Inhibitors: Daclatasvir and Synergists”

PLACE: Knobbe ... 阅读全帖
j****u
发帖数: 1413
12
2015年8月22日,波士顿科大校友会将举办首次医药行业的校友沙龙聚会。我们邀请到
了波士顿医药界三位资深校友陈寅(808),金晓玮(843) 和李劲波(863)为我们做嘉宾演
讲,纵论中美医药行业发展的机遇和挑战并分享作为科大校友在医药行业发展的心得体
会。欢迎中国科大校友参加,一同欢聚在查尔斯河河畔!
通知网址:http://ustcbaa.com/events/%E6%B3%A2%E5%A3%AB%E9%A1%BF%E4%B8%AD%E5%9B%BD%E7%A7%91%E5%A4%A7%E6%A0%A1%E5%8F%8B%E6%91%86%E4%B8%8B%E9%BE%99%E9%97%A8%E9%98%B5%E5%A4%A7%E8%AF%9D%E5%8C%BB%E8%8D%AF%E5%88%9B%E6%96%B0%E9%A2%86%E5%9F%9F/
时间: 2015年8月22日14:00-16:00
地点:220 Longwood Ave, Boston, MA。 教室 Goldenson 122, Harvard Medical
School(周围停车较不便, 可乘坐绿线... 阅读全帖
v****a
发帖数: 121
13
来自主题: Biology版 - Papers Help, Thank you
1 The title is: Strong enhancement of recombinant cytosine deaminase
activity in Bifidobacterium longum for tumor-targeting enzyme/prodrug
therapy
The link is: http://www.ncbi.nlm.nih.gov/pubmed/17420581
2 The title is: Tumor-targeted Salmonella as a Novel Anticancer Vector
The link is: http://cancerres.aacrjournals.org/content/57/20/4537.abstract
Please send to c***[email protected]
Thanks.
l*********1
发帖数: 351
14
来自主题: Biology版 - 问一个intracellular GSH的问题
说不定是个prodrug,GS攻击一下,生成活性药物.没啥奇怪的吧.
L*******a
发帖数: 824
15
The position is available immediately at Department of Pharmaceutical
Sciences, College of Pharmacy, University of Nebraska Medical Center, under
the mentoring of Dr. Dong Wang. Our research interests are:
Macromolecular therapies for inflammatory diseases.
Dentrotropic therapies for oral and craniofacial diseases.
Targeted therapies for musculoskeletal diseases.
Click chemistry for drug delivery and nanomedicine.
Biocompatible polymers for biomedical applications.
Prodru... 阅读全帖
r*********w
发帖数: 119
16
来自主题: Biology版 - 文献下载求助
请好心人帮忙!我们学校没有购买这个杂志的access。
多谢!
我的邮箱是:i**********[email protected]
文献见下面(九篇)。多谢啦!
Peptide-Based Therapeutic Approaches for Treatment of the Polyglutamine
Diseases.
Takeuchi T, Popiel HA, Futaki S, Wada K, Nagai Y.
Curr Med Chem. 2014 Feb 17. [Epub ahead of print]
A Translational View of Peptide Treatment of Neurological Disorders.
Brinker T.
Curr Med Chem. 2014 Feb 17. [Epub ahead of print]
Davunetide: Peptide Therapeutic in Neurological Disorders.
Magen I, Gozes I.
Curr Med Chem. 2014 Feb 17. [Epub a... 阅读全帖
d****i
发帖数: 360
17
来自主题: Chemistry版 - One paper please! Thanks a lot!
One paper please! Thanks a lot! E-mail: x**********[email protected]
Bioreduction activated prodrugs of camptothecin: Molecular design, synthesis
, activation mechanism and hypoxia selective cytotoxicity
Show Abstract Zhang, Z., Tanabe, K., Hatta, H., Nishimoto, S.-I. 2005
Organic and Biomolecular Chemistry 3 (10), pp. 1905-1910
v****a
发帖数: 121
18
来自主题: Chemistry版 - Papers Help, Thank you
1 The title is: Strong enhancement of recombinant cytosine deaminase
activity in Bifidobacterium longum for tumor-targeting enzyme/prodrug
therapy
The link is: http://www.ncbi.nlm.nih.gov/pubmed/17420581
2 The title is: Tumor-targeted Salmonella as a Novel Anticancer Vector
The link is: http://cancerres.aacrjournals.org/content/57/20/4537.abstract
Please send to c***[email protected]
Thanks.
w*q
发帖数: 1294
19
来自主题: Chemistry版 - Papers Help, Thank you
Strong enhancement of recombinant cytosine deaminase activity in
Bifidobacterium longum for tumor-targeting enzyme/prodrug therapy
http://www.sendspace.com/file/n9h4tc
c******6
发帖数: 928
20
来自主题: Chemistry版 - Paper help, many thanks!
Yanke Yu and Duxin Sun. "Superparamagnetic iron oxide nanoparticle ‘
theranostics’ for multimodality tumor imaging, gene delivery, targeted drug
and prodrug delivery". Expert Review of Clinical Pharmacology, 2010, Vol. 3
, No. 1, Pages 117-130.
W*******e
发帖数: 817
21
来自主题: Chemistry版 - 包子求papers
求3篇文献:
1, A facile and efficient approach to N-protected-β-sulfinyl- enamines via
C-sulfinylation of enamides and enecarbamates , Li, Yinhui; Cheng, Ke; Lu,
Xiaoxia; Sun, Jian, Advanced Synthesis & Catalysis (2010), 352(11+12), 1876-
1880
2, Mild and general method for the synthesis of sulfonamides, Ruano, Jose
Luis Garcia; Parra, Alejandro; Yuste, Francisco; Mastranzo, Virginia M.
Synthesis (2008), (2), 311-319
3,A straightforward route to Piloty's acid derivatives: a class of
potential nitrox... 阅读全帖
L*******a
发帖数: 824
22
The position is available immediately at Department of Pharmaceutical
Sciences, College of Pharmacy, University of Nebraska Medical Center, under
the mentoring of Dr. Dong Wang. Our research interests are:
Macromolecular therapies for inflammatory diseases.
Dentrotropic therapies for oral and craniofacial diseases.
Targeted therapies for musculoskeletal diseases.
Click chemistry for drug delivery and nanomedicine.
Biocompatible polymers for biomedical applications.
Prodru... 阅读全帖
b*******g
发帖数: 1309
23
来自主题: Chemistry版 - paper help, 3x!
http://www.ingentaconnect.com/content/asp/jnn/2011/00000011/000
J Nanosci Nanotechnol. 2011 Apr;11(4):3075-83.
Enzymatic activation of a peptide functionalised gold nanoparticle system
for prodrug delivery.
Pietersen LK, Govender P, Kruger HG, Maguire GE, Govender T.
Thanks a lot,
send to b***********[email protected]
r*********w
发帖数: 119
24
来自主题: Chemistry版 - 文献下载求助
请好心人帮忙!我们学校没有购买这个杂志的access。
多谢!
我的邮箱是:i**********[email protected]
文献见下面(九篇)。多谢啦!
Peptide-Based Therapeutic Approaches for Treatment of the Polyglutamine
Diseases.
Takeuchi T, Popiel HA, Futaki S, Wada K, Nagai Y.
Curr Med Chem. 2014 Feb 17. [Epub ahead of print]
A Translational View of Peptide Treatment of Neurological Disorders.
Brinker T.
Curr Med Chem. 2014 Feb 17. [Epub ahead of print]
Davunetide: Peptide Therapeutic in Neurological Disorders.
Magen I, Gozes I.
Curr Med Chem. 2014 Feb 17. [Epub a... 阅读全帖
L*******a
发帖数: 824
25
The position is available immediately at Department of Pharmaceutical
Sciences, College of Pharmacy, University of Nebraska Medical Center, under
the mentoring of Dr. Dong Wang. Our research interests are:
Macromolecular therapies for inflammatory diseases.
Dentrotropic therapies for oral and craniofacial diseases.
Targeted therapies for musculoskeletal diseases.
Click chemistry for drug delivery and nanomedicine.
Biocompatible polymers for biomedical applications.
Prodru... 阅读全帖
U******m
发帖数: 423
26
来自主题: Pharmaceutical版 - 求助!
酰胺不能作成盐酸盐,但可以考虑酰胺的氢原子的弱酸性,做成碱金属盐。
可以考虑做prodrug。
R*j
发帖数: 248
27
来自主题: Pharmaceutical版 - 请问drug delivery方向前景
不是大牛,也能说两句吗?
drug delivery的覆盖范围更大点,包括传统的formulation和其他一些现代的技术,比
如prodrug。其实像osmotic pump, needless syringe,drug-coated coronary stent
这种东西也可以叫drug delivery.
现在没人特意抠这个字眼。
R******d
发帖数: 5739
28
来自主题: Pharmaceutical版 - 药物设计中亲疏水平衡的把握

ur molecule need to be lipophilic in order to pass the cell membrane(lipid
bilayer), if it is hydrophilic, then u need active transport. but as what u
said, too lipophilic will decrease solubility and cause PK, protein binding
, etc. problems. it is a balance. in some cases i saw solubility gave in
to potency, then people will try to make salt, or prodrugs to get around the
solubility problem
L*******a
发帖数: 824
29
The position is available immediately at Department of Pharmaceutical
Sciences, College of Pharmacy, University of Nebraska Medical Center, under
the mentoring of Dr. Dong Wang. Our research interests are:
Macromolecular therapies for inflammatory diseases.
Dentrotropic therapies for oral and craniofacial diseases.
Targeted therapies for musculoskeletal diseases.
Click chemistry for drug delivery and nanomedicine.
Biocompatible polymers for biomedical applications.
Prodru... 阅读全帖
a*****8
发帖数: 2115
30
来自主题: Medicalpractice版 - 求救,老人在重病中
Totally, you will need to know MIC (minimum inhibitory concentration) of
Acinetobactor to colistin. Also colistin is a prodrug, with a very good
renal function, you might not achieve adequate serum concentration
especially in CNS.
Also, what is Serum creatinine?
Colistin dosing is always a controversial topic. Even in US, it is not seen
commonly.
Honestly, at this point, it is difficult to provide a dose.
With current dose, how is patient doing?
Also, in US, colistin product is colistin sodium w... 阅读全帖
X*****s
发帖数: 2767
31
来自主题: _Stockcafeteria版 - 几个股票
在IDIX官网上看到如下关于clinical
trial的报道 (http://phx.corporate-ir.net/phoenix.zhtml?c=131556&p=irol-newsArticle_print&ID=1706684&highlight=)。eRVR的比率和vertex的药incivek都是58%,cEVR的比率和vertex的药incivek几乎一样(86%),关于eRVR和cEVR这个链接有解释http://www.natap.org/2007/AASLD/AASLD_56.htm。目前来看,药效很让人鼓舞,而且idix的药是Nucleoside/tide Polymerase Inhibitor,抵制抗药性,每日口服一次。一个潜在的问题是idix-184和gilead的gs-7977是一个机理的,但gs-7977出现了病毒反复,股价在2月份一下之掉了15%,
CAMBRIDGE, Mass., June 19, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals,
Inc. (Nasdaq:IDIX), a b... 阅读全帖
r***e
发帖数: 653
32
2月份,PLX (2/7), DDSS (2/11), CADX(2/12), XNPT (2/9), CTIC (2/10,Panel
Review), CRXX(2/22,估计要被据)
3月份: SUPG (3/8, 不是SUPG自己的), APPA (3/18,估计很玄), SOMX (3/21, 三进宫了),MNTA (3/31), STAA (3/31),
4月份:CYTX(4/7),CTIC(4/23,估计2月10结果就差不多出来了),POZN(4/30),
PLX: taliglucerase alfa for Gaucher's disease, FDA orphan drug and fast
track designation, 有pfizer的背书,临床结果好于竞争对手Genzyme的Cerezyme.三期
临床试验证明了安全和疗效,作为一个protein drug,只有6%的病人体内产生抗体.结果
不错.
DDSS:去年7月份悲剧是因为生产设施的问题,FDA没提疗效和安全的问题.这次是志在必
得.
CADX:IV acetaminophen (Acetavanc... 阅读全帖
e*n
发帖数: 1511
33
来自主题: _pennystock版 - IDIX KID
Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the
discovery and development of drugs for the treatment of human viral and
other infectious diseases in the United States and Europe. The company
primarily focuses its research and development on the treatment for
hepatitis C virus. The company develops nucleoside/nucleotide polymerase
inhibitors, including IDX184, a liver-targeted nucleotide prodrug candidate,
which is in phase IIa clinical trial; and IDX102 that completed l... 阅读全帖
1 (共1页)